Cancer cells suppress NK cell function through expression of TGF-β, IL-10, indoleamine 2,3-dioxygenase (IDO), and matrix metalloproteinases (MMPs), which impair NK cell tumor recognition and killing via the downregulation of cytotoxicity receptors. Here, TGFB1 is linked to cancer.